Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.50
+0.89993.98%
Volume:2K
Turnover:39.59K
Market Cap:4.70M
PE:- -
High:23.62
Open:23.49
Low:23.44
Close:22.60
52wk High:24.74
52wk Low:15.67
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.85
T/O Rate:0.84%
Dividend:0.77
Dividend Rate:3.28%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc. Stock Rises 4.8%, Outperforms Peers

Dow Jones
·
Oct 08

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 08

Twist Bioscience CEO Emily M. Leproust Disposes of USD 910,033 in Common Shares

Reuters
·
Oct 08

Moderna, Merck Climb on Collaboration with Tempus

Reuters
·
Oct 08

Eli Lilly and Co Stock (LLY) Moved Up by 3.94% on Oct 7: Facts Behind the Movement

TradingKey
·
Oct 08

Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis

TradingKey
·
Oct 08

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Oct 08

Twist Bioscience Price Target Raised to $215.00/Share from $112.00 by Barclays

Dow Jones
·
Oct 07

Pharma Lobby Sues Trump Administration over Medicare Drug Price Cuts

Reuters
·
Oct 07

Moderna Price Target Raised to $95.00/Share from $89.00 by Morgan Stanley

Dow Jones
·
Oct 07

Eli Lilly is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Oct 07

What Eli Lilly Stock's First Line Jaypirca Approval Means For Shareholders

Simply Wall St.
·
Oct 07

Morgan Stanley Adjusts Price Target on Moderna to $95 From $89

MT Newswires Live
·
Oct 07

Tempus AI announces multi-year collaboration with Moderna, Merck

TIPRANKS
·
Oct 07

Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support

Reuters
·
Oct 07

Tempus Announces Multi-Year Collaboration with Moderna and Merck

THOMSON REUTERS
·
Oct 07

Morgan Stanley Adjusts Price Target on Eli Lilly to $1,430 From $1,419

MT Newswires Live
·
Oct 07

Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare

Dow Jones
·
Oct 07

AlzeCure Pharma to Present at Redeye Neurology Day

Reuters
·
Oct 07

Barclays Remains a Buy on Twist Bioscience (TWST)

TIPRANKS
·
Oct 07